InvestorsHub Logo
Followers 556
Posts 17434
Boards Moderated 42
Alias Born 10/21/2003

Re: None

Friday, 03/01/2019 4:09:08 PM

Friday, March 01, 2019 4:09:08 PM

Post# of 10796
acrx $3.66 Acelrx just got a drug approved in November 2018. It's an opioid pain reliever delivered via an under the tongue device. FDA approved for medical facilities only. Not going to be prescribed thru local drug store/pharmacy. So little chance of ending up being abused.

Drug has been around for decades but under tongue application is new.

Company has issued stock recently to raise money for sales campaign. Stock shot up briefly after approval in November but quickly fell. Company starting sales in Q1 so this month.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146703815

this link connects you to ACRX news conference where they discussed plans for the drug and why company thinks it's going to be successful. More importantly, this news conference included a panel of experts from hospitals who discussed the pluses and minuses of this drug and it's benefits to emergency rooms and day surgery centers. That's the first target for ACELRX.

Price targets for ACELRX range from 9 to $12.

Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.

If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.